Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1992 Sep;60(9):3731–3738. doi: 10.1128/iai.60.9.3731-3738.1992

Effects of cytokines, complement, and antibody on the neutrophil respiratory burst and phagocytic response to Plasmodium falciparum merozoites.

L M Kumaratilake 1, A Ferrante 1, T Jaeger 1, C M Rzepczyk 1
PMCID: PMC257384  PMID: 1500183

Abstract

The interaction between Plasmodium falciparum merozoites and human neutrophils, as well as the role of cytokines, complement, and antimalarial antibody on this interaction, was examined in vitro by measuring luminol-dependent chemiluminescence and phagocytosis. Merozoites, in the presence of heat-inactivated (56 degrees C/30 min) normal serum, had very little effect on the neutrophil chemiluminescence. This response was significantly enhanced by the addition of normal serum (containing normal complement activity). In the presence of serum or plasma containing anti-P. falciparum antibodies (IS) with no detectable complement activity, the merozoites induced a marked response characterized by an increase in initial peak rate of chemiluminescence and a sustained increased rate of chemiluminescence. However, this response was not further increased if IS containing complement activity was used. Pretreatment of neutrophils with either tumor necrosis factor alpha, lymphotoxin, or gamma interferon significantly increased the neutrophil response to IS-treated merozoites, reflected in an increased initial peak rate and sustained increased rate of chemiluminescence. The effects of cytokine treatment of neutrophils and IS opsonization of merozoites were synergistic. In association with the changes in the chemiluminescence responses, IS was shown to promote phagocytosis of merozoites by neutrophils, and this event was further increased by treating neutrophils with the cytokines. The results emphasize the importance of antibody and cytokines in neutrophil-mediated damage of P. falciparum merozoites.

Full text

PDF
3731

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison A. C., Eugui E. M. The role of cell-mediated immune responses in resistance to malaria, with special reference to oxidant stress. Annu Rev Immunol. 1983;1:361–392. doi: 10.1146/annurev.iy.01.040183.002045. [DOI] [PubMed] [Google Scholar]
  2. Atkinson Y. H., Marasco W. A., Lopez A. F., Vadas M. A. Recombinant human tumor necrosis factor-alpha. Regulation of N-formylmethionylleucylphenylalanine receptor affinity and function on human neutrophils. J Clin Invest. 1988 Mar;81(3):759–765. doi: 10.1172/JCI113381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bouharoun-Tayoun H., Attanath P., Sabchareon A., Chongsuphajaisiddhi T., Druilhe P. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J Exp Med. 1990 Dec 1;172(6):1633–1641. doi: 10.1084/jem.172.6.1633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Campbell P. A. The neutrophil, a professional killer of bacteria, may be controlled by T cells. Clin Exp Immunol. 1990 Feb;79(2):141–143. doi: 10.1111/j.1365-2249.1990.tb05169.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chizzolini C., Grau G. E., Geinoz A., Schrijvers D. T lymphocyte interferon-gamma production induced by Plasmodium falciparum antigen is high in recently infected non-immune and low in immune subjects. Clin Exp Immunol. 1990 Jan;79(1):95–99. doi: 10.1111/j.1365-2249.1990.tb05133.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Clark I. A. Cell-mediated immunity in protection and pathology of malaria. Parasitol Today. 1987 Oct;3(10):300–305. doi: 10.1016/0169-4758(87)90187-6. [DOI] [PubMed] [Google Scholar]
  7. Clark J. T., Donachie S., Anand R., Wilson C. F., Heidrich H. G., McBride J. S. 46-53 kilodalton glycoprotein from the surface of Plasmodium falciparum merozoites. Mol Biochem Parasitol. 1989 Jan 1;32(1):15–24. doi: 10.1016/0166-6851(89)90125-4. [DOI] [PubMed] [Google Scholar]
  8. Czuprynski C. J., Brown J. F. Dual regulation of anti-bacterial resistance and inflammatory neutrophil and macrophage accumulation by L3T4+ and Lyt 2+ Listeria-immune T cells. Immunology. 1987 Feb;60(2):287–293. [PMC free article] [PubMed] [Google Scholar]
  9. Czuprynski C. J., Henson P. M., Campbell P. A. Enhanced accumulation of inflammatory neutrophils and macrophages mediated by transfer of T cells from mice immunized with Listeria monocytogenes. J Immunol. 1985 May;134(5):3449–3454. [PubMed] [Google Scholar]
  10. Denis M., Chadee K. Human neutrophils activated by interferon-gamma and tumour necrosis factor-alpha kill Entamoeba histolytica trophozoites in vitro. J Leukoc Biol. 1989 Sep;46(3):270–274. doi: 10.1002/jlb.46.3.270. [DOI] [PubMed] [Google Scholar]
  11. Djeu J. Y., Blanchard D. K., Halkias D., Friedman H. Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor. J Immunol. 1986 Nov 1;137(9):2980–2984. [PubMed] [Google Scholar]
  12. Druilhe P., Khusmith S. Epidemiological correlation between levels of antibodies promoting merozoite phagocytosis of Plasmodium falciparum and malaria-immune status. Infect Immun. 1987 Apr;55(4):888–891. doi: 10.1128/iai.55.4.888-891.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Edwards S. W., Say J. E., Hughes V. Gamma interferon enhances the killing of Staphylococcus aureus by human neutrophils. J Gen Microbiol. 1988 Jan;134(1):37–42. doi: 10.1099/00221287-134-1-37. [DOI] [PubMed] [Google Scholar]
  14. Epping R. J., Goldstone S. D., Ingram L. T., Upcroft J. A., Ramasamy R., Cooper J. A., Bushell G. R., Geysen H. M. An epitope recognised by inhibitory monoclonal antibodies that react with a 51 kilodalton merozoite surface antigen in Plasmodium falciparum. Mol Biochem Parasitol. 1988 Feb;28(1):1–10. doi: 10.1016/0166-6851(88)90173-9. [DOI] [PubMed] [Google Scholar]
  15. Ferrante A., Kumaratilake L., Rzepczyk C. M., Dayer J. M. Killing of Plasmodium falciparum by cytokine activated effector cells (neutrophils and macrophages). Immunol Lett. 1990 Aug;25(1-3):179–187. doi: 10.1016/0165-2478(90)90112-4. [DOI] [PubMed] [Google Scholar]
  16. Ferrante A., Nandoskar M., Bates E. J., Goh D. H., Beard L. J. Tumour necrosis factor beta (lymphotoxin) inhibits locomotion and stimulates the respiratory burst and degranulation of neutrophils. Immunology. 1988 Mar;63(3):507–512. [PMC free article] [PubMed] [Google Scholar]
  17. Ferrante A., Nandoskar M., Walz A., Goh D. H., Kowanko I. C. Effects of tumour necrosis factor alpha and interleukin-1 alpha and beta on human neutrophil migration, respiratory burst and degranulation. Int Arch Allergy Appl Immunol. 1988;86(1):82–91. doi: 10.1159/000234610. [DOI] [PubMed] [Google Scholar]
  18. Ferrante A., Staugas R. E., Rowan-Kelly B., Bresatz S., Kumaratilake L. M., Rzepczyk C. M., Adolf G. R. Production of tumor necrosis factors alpha and beta by human mononuclear leukocytes stimulated with mitogens, bacteria, and malarial parasites. Infect Immun. 1990 Dec;58(12):3996–4003. doi: 10.1128/iai.58.12.3996-4003.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ferrante A., Thong Y. H. Optimal conditions for simultaneous purification of mononuclear and polymorphonuclear leucocytes from human blood by the Hypaque-Ficoll method. J Immunol Methods. 1980;36(2):109–117. doi: 10.1016/0022-1759(80)90036-8. [DOI] [PubMed] [Google Scholar]
  20. Ferrante A. Tumor necrosis factor alpha potentiates neutrophil antimicrobial activity: increased fungicidal activity against Torulopsis glabrata and Candida albicans and associated increases in oxygen radical production and lysosomal enzyme release. Infect Immun. 1989 Jul;57(7):2115–2122. doi: 10.1128/iai.57.7.2115-2122.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Filice G. A., Niewoehner D. E. Contribution of neutrophils and cell-mediated immunity to control of Nocardia asteroides in murine lungs. J Infect Dis. 1987 Jul;156(1):113–121. doi: 10.1093/infdis/156.1.113. [DOI] [PubMed] [Google Scholar]
  22. Gamble J. R., Harlan J. M., Klebanoff S. J., Vadas M. A. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc Natl Acad Sci U S A. 1985 Dec;82(24):8667–8671. doi: 10.1073/pnas.82.24.8667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Geertsma M. F., Nibbering P. H., Pos O., Van Furth R. Interferon-gamma-activated human granulocytes kill ingested Mycobacterium fortuitum more efficiently than normal granulocytes. Eur J Immunol. 1990 Apr;20(4):869–873. doi: 10.1002/eji.1830200423. [DOI] [PubMed] [Google Scholar]
  24. Grau G. E., Modlin R. L. Immune mechanisms in bacterial and parasitic diseases: protective immunity versus pathology. Curr Opin Immunol. 1991 Aug;3(4):480–485. doi: 10.1016/0952-7915(91)90007-n. [DOI] [PubMed] [Google Scholar]
  25. Grau G. E., Piguet P. F., Vassalli P., Lambert P. H. Involvement of tumour necrosis factor and other cytokines in immune-mediated vascular pathology. Int Arch Allergy Appl Immunol. 1989;88(1-2):34–39. doi: 10.1159/000234744. [DOI] [PubMed] [Google Scholar]
  26. Grau G. E., Taylor T. E., Molyneux M. E., Wirima J. J., Vassalli P., Hommel M., Lambert P. H. Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med. 1989 Jun 15;320(24):1586–1591. doi: 10.1056/NEJM198906153202404. [DOI] [PubMed] [Google Scholar]
  27. Gresham H. D., Clement L. T., Lehmeyer J. E., Griffin F. M., Jr, Volanakis J. E. Stimulation of human neutrophil Fc receptor-mediated phagocytosis by a low molecular weight cytokine. J Immunol. 1986 Aug 1;137(3):868–875. [PubMed] [Google Scholar]
  28. Gresham H. D., Graham I. L., Anderson D. C., Brown E. J. Leukocyte adhesion-deficient neutrophils fail to amplify phagocytic function in response to stimulation. Evidence for CD11b/CD18-dependent and -independent mechanisms of phagocytosis. J Clin Invest. 1991 Aug;88(2):588–597. doi: 10.1172/JCI115343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Gresham H. D., Zheleznyak A., Mormol J. S., Brown E. J. Studies on the molecular mechanisms of human neutrophil Fc receptor-mediated phagocytosis. Evidence that a distinct pathway for activation of the respiratory burst results in reactive oxygen metabolite-dependent amplification of ingestion. J Biol Chem. 1990 May 15;265(14):7819–7826. [PubMed] [Google Scholar]
  30. Jaffe C. J., Atkinson J. P., Frank M. M. The role of complement in the clearance of cold agglutinin-sensitized erythrocytes in man. J Clin Invest. 1976 Oct;58(4):942–949. doi: 10.1172/JCI108547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Khan Z. M., Vanderberg J. P. Role of host cellular response in differential susceptibility of nonimmunized BALB/c mice to Plasmodium berghei and Plasmodium yoelii sporozoites. Infect Immun. 1991 Aug;59(8):2529–2534. doi: 10.1128/iai.59.8.2529-2534.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Kharazmi A., Jepsen S., Andersen B. J. Generation of reactive oxygen radicals by human phagocytic cells activated by Plasmodium falciparum. Scand J Immunol. 1987 Apr;25(4):335–341. doi: 10.1111/j.1365-3083.1987.tb02198.x. [DOI] [PubMed] [Google Scholar]
  33. Khusmith S., Druilhe P., Gentilini M. Enhanced Plasmodium falciparum merozoite phagocytosis by monocytes from immune individuals. Infect Immun. 1982 Mar;35(3):874–879. doi: 10.1128/iai.35.3.874-879.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Kilejian A., Abati A., Trager W. Plasmodium falciparum and Plasmodium coatneyi: immunogenicity of "knob-like protrusions" on infected erythrocyte membranes. Exp Parasitol. 1977 Jun;42(1):157–164. doi: 10.1016/0014-4894(77)90073-x. [DOI] [PubMed] [Google Scholar]
  35. Klebanoff S. J., Vadas M. A., Harlan J. M., Sparks L. H., Gamble J. R., Agosti J. M., Waltersdorph A. M. Stimulation of neutrophils by tumor necrosis factor. J Immunol. 1986 Jun 1;136(11):4220–4225. [PubMed] [Google Scholar]
  36. Kowanko I. C., Ferrante A. Stimulation of neutrophil respiratory burst and lysosomal enzyme release by human interferon-gamma. Immunology. 1987 Sep;62(1):149–151. [PMC free article] [PubMed] [Google Scholar]
  37. Kumaratilake L. M., Ferrante A., Bates E. J., Kowanko I. C. Augmentation of the human monocyte/macrophage chemiluminescence response during short-term exposure to interferon-gamma and tumour necrosis factor-alpha. Clin Exp Immunol. 1990 May;80(2):257–262. doi: 10.1111/j.1365-2249.1990.tb05244.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Kumaratilake L. M., Ferrante A. IL-4 inhibits macrophage-mediated killing of Plasmodium falciparum in vitro. A possible parasite-immune evasion mechanism. J Immunol. 1992 Jul 1;149(1):194–199. [PubMed] [Google Scholar]
  39. Kumaratilake L. M., Ferrante A., Rzepczyk C. M. Tumor necrosis factor enhances neutrophil-mediated killing of Plasmodium falciparum. Infect Immun. 1990 Mar;58(3):788–793. doi: 10.1128/iai.58.3.788-793.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Kumaratilake L. M., Ferrante A., Rzepczyk C. The role of T lymphocytes in immunity to Plasmodium falciparum. Enhancement of neutrophil-mediated parasite killing by lymphotoxin and IFN-gamma: comparisons with tumor necrosis factor effects. J Immunol. 1991 Jan 15;146(2):762–767. [PubMed] [Google Scholar]
  41. Kumaratilake L. M., Robinson B. S., Ferrante A., Poulos A. Antimalarial properties of n-3 and n-6 polyunsaturated fatty acids: in vitro effects on Plasmodium falciparum and in vivo effects on P. berghei. J Clin Invest. 1992 Mar;89(3):961–967. doi: 10.1172/JCI115678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Mitchell G. H., Richards W. H., Butcher G. A., Cohen S. Merozoite vaccination of douroucouli monkeys against falciparum malaria. Lancet. 1977 Jun 25;1(8026):1335–1338. doi: 10.1016/s0140-6736(77)92551-x. [DOI] [PubMed] [Google Scholar]
  43. NIH conference. Pathophysiology of immune hemolytic anemia. Ann Intern Med. 1977 Aug;87(2):210–222. doi: 10.7326/0003-4819-87-2-210. [DOI] [PubMed] [Google Scholar]
  44. Ockenhouse C. F., Schulman S., Shear H. L. Induction of crisis forms in the human malaria parasite Plasmodium falciparum by gamma-interferon-activated, monocyte-derived macrophages. J Immunol. 1984 Sep;133(3):1601–1608. [PubMed] [Google Scholar]
  45. Perrin L. H., Merkli B., Gabra M. S., Stocker J. W., Chizzolini C., Richle R. Immunization with a Plasmodium falciparum merozoite surface antigen induces a partial immunity in monkeys. J Clin Invest. 1985 May;75(5):1718–1721. doi: 10.1172/JCI111881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Perussia B., Kobayashi M., Rossi M. E., Anegon I., Trinchieri G. Immune interferon enhances functional properties of human granulocytes: role of Fc receptors and effect of lymphotoxin, tumor necrosis factor, and granulocyte-macrophage colony-stimulating factor. J Immunol. 1987 Feb 1;138(3):765–774. [PubMed] [Google Scholar]
  47. Pirson P. J., Perkins M. E. Characterization with monoclonal antibodies of a surface antigen of Plasmodium falciparum merozoites. J Immunol. 1985 Mar;134(3):1946–1951. [PubMed] [Google Scholar]
  48. Rhodes-Feuillette A., Bellosguardo M., Druilhe P., Ballet J. J., Chousterman S., Canivet M., Périès J. The interferon compartment of the immune response in human malaria: II. Presence of serum-interferon gamma following the acute attack. J Interferon Res. 1985 Winter;5(1):169–178. doi: 10.1089/jir.1985.5.169. [DOI] [PubMed] [Google Scholar]
  49. Ridley R. G., Takacs B., Etlinger H., Scaife J. G. A rhoptry antigen of Plasmodium falciparum is protective in Saimiri monkeys. Parasitology. 1990 Oct;101(Pt 2):187–192. doi: 10.1017/s0031182000063228. [DOI] [PubMed] [Google Scholar]
  50. Rzepczyk C. M., Ramasamy R., Mutch D. A., Ho P. C., Battistutta D., Anderson K. L., Parkinson D., Doran T. J., Honeyman M. Analysis of human T cell response to two Plasmodium falciparum merozoite surface antigens. Eur J Immunol. 1989 Oct;19(10):1797–1802. doi: 10.1002/eji.1830191006. [DOI] [PubMed] [Google Scholar]
  51. Saul A. Kinetic constraints on the development of a malaria vaccine. Parasite Immunol. 1987 Jan;9(1):1–9. doi: 10.1111/j.1365-3024.1987.tb00483.x. [DOI] [PubMed] [Google Scholar]
  52. Schulkind M. L., Ellis E. F., Smith R. T. Effect of antibody upon clearance of I-125-labelled pneumococci by the spleen and liver. Pediatr Res. 1967 May;1(3):178–184. doi: 10.1203/00006450-196705000-00004. [DOI] [PubMed] [Google Scholar]
  53. Shaffer N., Grau G. E., Hedberg K., Davachi F., Lyamba B., Hightower A. W., Breman J. G., Phuc N. D. Tumor necrosis factor and severe malaria. J Infect Dis. 1991 Jan;163(1):96–101. doi: 10.1093/infdis/163.1.96. [DOI] [PubMed] [Google Scholar]
  54. Siddiqui W. A., Tam L. Q., Kramer K. J., Hui G. S., Case S. E., Yamaga K. M., Chang S. P., Chan E. B., Kan S. C. Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria. Proc Natl Acad Sci U S A. 1987 May;84(9):3014–3018. doi: 10.1073/pnas.84.9.3014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Steinbeck M. J., Roth J. A. Neutrophil activation by recombinant cytokines. Rev Infect Dis. 1989 Jul-Aug;11(4):549–568. doi: 10.1093/clinids/11.4.549. [DOI] [PubMed] [Google Scholar]
  56. Stevenson M. M., Nowotarski M., Yap G. Review: cytokines and malaria. Clin Invest Med. 1990 Dec;13(6):353–359. [PubMed] [Google Scholar]
  57. Sun T., Chakrabarti C. Schizonts, merozoites, and phagocytosis in falciparum malaria. Ann Clin Lab Sci. 1985 Nov-Dec;15(6):465–469. [PubMed] [Google Scholar]
  58. Theander T. G., Andersen B. J., Pedersen B. K., Jepsen S., Bygbjerg I. C., Hviid L., Larsen P. B., Kharazmi A. Cell-mediated immunity to Plasmodium falciparum infection: evidence against the involvement of cytotoxic lymphocytes. Scand J Immunol. 1988 Jul;28(1):105–111. doi: 10.1111/j.1365-3083.1988.tb02421.x. [DOI] [PubMed] [Google Scholar]
  59. Trubowitz S., Masek B. Plasmodium falciparum: phagocytosis by polymorphonuclear leukocytes. Science. 1968 Oct 11;162(3850):273–274. doi: 10.1126/science.162.3850.273. [DOI] [PubMed] [Google Scholar]
  60. Vernot J. P., Wasserman M. Plasmodium falciparum: increased and multiple invasion during short periods of time. J Protozool. 1990 Jan-Feb;37(1):47–49. doi: 10.1111/j.1550-7408.1990.tb01113.x. [DOI] [PubMed] [Google Scholar]
  61. Wara D. W. Host defense against Streptococcus pneumoniae: the role of the spleen. Rev Infect Dis. 1981 Mar-Apr;3(2):299–309. doi: 10.1093/clinids/3.2.299. [DOI] [PubMed] [Google Scholar]
  62. Weiss W. R., Sedegah M., Beaudoin R. L., Miller L. H., Good M. F. CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc Natl Acad Sci U S A. 1988 Jan;85(2):573–576. doi: 10.1073/pnas.85.2.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Wåhlin B., Wahlgren M., Perlmann H., Berzins K., Björkman A., Patarroyo M. E., Perlmann P. Human antibodies to a Mr 155,000 Plasmodium falciparum antigen efficiently inhibit merozoite invasion. Proc Natl Acad Sci U S A. 1984 Dec;81(24):7912–7916. doi: 10.1073/pnas.81.24.7912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Zhang J. H., Ferrante A., Arrigo A. P., Dayer J. M. Neutrophil stimulation and priming by direct contact with activated human T lymphocytes. J Immunol. 1992 Jan 1;148(1):177–181. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES